Top

Published in:

01-12-2020 | Guillain-Barré Syndrome | Original Article

Posterior reversible encephalopathy and Guillain–Barré syndrome: which came first, the chicken or the egg? A review of literature

Authors: Benedetta Storti, Marcella Vedovello, Riccardo Riva, Emanuela Agazzi, Bruno Censori, Ornella Manara, Maria Sessa, Maria Rosa Rottoli

Published in: Neurological Sciences | Issue 12/2020

Abstract

Posterior reversible encephalopathy (PRES) is a rare occurrence in patients with Guillain–Barré syndrome (GBS) with only nine adult cases reported to date. We conducted a review of the literature and compared previous cases with a novel case admitted to our clinic. In light of the timing of the symptoms, it is assumable that arterial hypertension can develop acutely during a phase of GBS-related autonomic dysfunction and subsequently precipitates PRES. According to this, dysautonomia caused by GBS could precede motor weakness; thus, PRES in the absence of any strong alternative etiology may suggest an underlying GBS.

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500CrossRef

Flachenecker P (2007) Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. J Neurol 254(Suppl II):96 – II–96 –101

Nabi S, Rajput HM, Badshah M, Ahmed S (2016) Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barré syndrome (GBS). BMJ Case Rep 2016:bcr2016216757CrossRef

Li C, Luo T, Cheng Y, Liu S, Qiao L, Wu X, Liu K (2020) The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barré syndrome. Neurol Sci. 41(2):295–303CrossRef

Nakajima M (2005) Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with miller-fisher syndrome. Eur Neurol 54(1):58–60CrossRef

Koichihara R, Hamano S, Yamashita S, Tanaka M (2008) Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome. Pediatr Neurol 39:123–125CrossRef

Stetefeld HR, Lehmann HC, Fink GR, Burghaus L (2014) Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller-Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome. J Stroke Cerebrovasc Dis 23(9):e423–e425CrossRef

Incecik F, Hergüner MO, Altunbasak S, Yıldızdas D (2011) Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome. J Pediatr Neurosci 6(2):138–140PubMedPubMedCentral

Elahi A, Kelkar P, Louis EKS (2004) Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome. Neurocrit Care 1:465–468CrossRef

10.

Van Diest D, Van Goethem JW, Vercruyssen A, Jadoul C, Cras P (2007) Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: coincidence or causative relation? Clin Neurol Neurosurg. 109(1):58–62CrossRef

11.

Sutter R, Mengiardi B, Lyrer P, Czaplinski A (2009) Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome. Neuromuscul Disord. 19(10):709–710CrossRef

12.

Bavikatte G, Gaber T, Eshiett MU (2010) Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome. J Clin Neurosci. 17(7):924–926CrossRef

13.

Abraham A, Ziv S, Drory VE (2011) Posterior reversible encephalopathy syndrome resulting from Guillain-Barré-like syndrome secondary to West Nile virus infection. J Clin Neuromuscul Dis. 12(3):113–117CrossRef

14.

Etxeberria A, Lonneville S, Rutgers MP, Gille M (2012) Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome. Rev Neurol (Paris). 168(3):283–286CrossRef

15.

Rigamonti A, Basso F, Scaccabarozzi C, Lauria G (2012) Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome: case report and review of the literature. J Peripher Nerv Syst 17:356–360CrossRef

16.

Yonekura S, Anno T, Kobayashi N (2018) Posterior reversible encephalopathy syndrome and Guillain-Barré syndrome after head injury: case report. Neurol Med Chir (Tokyo) 58(10):453–458CrossRef

17.

Drye C, Bose S, Pathireddy S, Aeddula NR (2019) Guillain-Barre syndrome with concurrent posterior reversible encephalopathy syndrome and hyponatraemia: mere coincidence or rare coexistence. BMJ Case Rep 12(7):e229749. https://doi.org/10.1136/bcr-2019-229749

18.

Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK, EMSA-SG (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25(15):2604–2612CrossRef

19.

Yuki N, Hartung HP (2012) Guillain-Barré syndrome. N Engl J Med 366(24):2294–2304CrossRef

Title: Posterior reversible encephalopathy and Guillain–Barré syndrome: which came first, the chicken or the egg? A review of literature
Authors: Benedetta Storti
Marcella Vedovello
Riccardo Riva
Emanuela Agazzi
Bruno Censori
Ornella Manara
Maria Sessa
Maria Rosa Rottoli
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keywords: Guillain-Barré Syndrome
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Hypertension
Encephalopathy
Arterial Hypertension
Arterial Hypertension
Published in: Neurological Sciences / Issue 12/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04496-1

At a glance: The STEP trials

Springer Medicine

Posterior reversible encephalopathy and Guillain–Barré syndrome: which came first, the chicken or the egg? A review of literature

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2020

MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development

Anti-LGI1 encephalitis in a middle-aged woman who consumes cannabis oil

Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes

Relationship between bone disorders and stroke

A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability

The utility of whole exome sequencing for identification of the molecular etiology in autosomal recessive developmental and epileptic encephalopathies